Qianjiang Yongan Pharmaceutical (002365.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue...
Zhicheng Finance and Economics APP News, Qianjiang Yongan Pharmaceutical (002365.SZ) released the third quarter report for 2024. In the first three quarters, the company achieved revenue of 0.619 billion yuan, a 22.93% year-on-year decrease. Net income attributable to shareholders of the listed company was 61.8552 million yuan, an increase of 33.23% year-on-year. Net profit attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 37.4882 million yuan, an increase of 489.66% year-on-year.